nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A1—mouth—Crohn's disease	0.0327	0.0986	CbGeAlD
Olopatadine—S100A2—epithelium—Crohn's disease	0.0206	0.0623	CbGeAlD
Olopatadine—S100A2—skin of body—Crohn's disease	0.0196	0.0592	CbGeAlD
Olopatadine—S100A1—skin of body—Crohn's disease	0.0181	0.0545	CbGeAlD
Olopatadine—S100A2—mammalian vulva—Crohn's disease	0.0179	0.054	CbGeAlD
Olopatadine—S100A13—epithelium—Crohn's disease	0.0169	0.0509	CbGeAlD
Olopatadine—S100A12—epithelium—Crohn's disease	0.0166	0.0502	CbGeAlD
Olopatadine—S100A13—smooth muscle tissue—Crohn's disease	0.0163	0.049	CbGeAlD
Olopatadine—S100A13—skin of body—Crohn's disease	0.016	0.0484	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—Crohn's disease	0.0159	0.0479	CbGeAlD
Olopatadine—S100B—skin of body—Crohn's disease	0.0156	0.0471	CbGeAlD
Olopatadine—S100A1—digestive system—Crohn's disease	0.0145	0.0436	CbGeAlD
Olopatadine—S100A12—mammalian vulva—Crohn's disease	0.0144	0.0435	CbGeAlD
Olopatadine—S100A13—Methyldopa—Mesalazine—Crohn's disease	0.0129	1	CbGdCrCtD
Olopatadine—S100A13—digestive system—Crohn's disease	0.0128	0.0387	CbGeAlD
Olopatadine—S100A12—lymphoid tissue—Crohn's disease	0.0128	0.0386	CbGeAlD
Olopatadine—S100A12—digestive system—Crohn's disease	0.0127	0.0382	CbGeAlD
Olopatadine—S100B—lymphoid tissue—Crohn's disease	0.0126	0.0381	CbGeAlD
Olopatadine—S100A1—lymph node—Crohn's disease	0.00826	0.0249	CbGeAlD
Olopatadine—Eye swelling—Mesalazine—Crohn's disease	0.00787	0.0561	CcSEcCtD
Olopatadine—S100A13—lymph node—Crohn's disease	0.00733	0.0221	CbGeAlD
Olopatadine—S100A12—lymph node—Crohn's disease	0.00723	0.0218	CbGeAlD
Olopatadine—S100B—lymph node—Crohn's disease	0.00714	0.0215	CbGeAlD
Olopatadine—Ulcer—Mercaptopurine—Crohn's disease	0.00499	0.0356	CcSEcCtD
Olopatadine—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0038	0.0271	CcSEcCtD
Olopatadine—Laryngeal pain—Mesalazine—Crohn's disease	0.00376	0.0268	CcSEcCtD
Olopatadine—HRH1—epithelium—Crohn's disease	0.00337	0.0102	CbGeAlD
Olopatadine—HRH1—smooth muscle tissue—Crohn's disease	0.00325	0.00979	CbGeAlD
Olopatadine—HRH1—mammalian vulva—Crohn's disease	0.00292	0.00881	CbGeAlD
Olopatadine—Endophthalmitis—Prednisone—Crohn's disease	0.00285	0.0203	CcSEcCtD
Olopatadine—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00282	0.0201	CcSEcCtD
Olopatadine—Cough increased—Mesalazine—Crohn's disease	0.0028	0.02	CcSEcCtD
Olopatadine—HRH1—digestive system—Crohn's disease	0.00256	0.00773	CbGeAlD
Olopatadine—Dry eye—Mesalazine—Crohn's disease	0.00237	0.0169	CcSEcCtD
Olopatadine—Immune system disorder—Mercaptopurine—Crohn's disease	0.00214	0.0153	CcSEcCtD
Olopatadine—Eye pain—Mesalazine—Crohn's disease	0.00206	0.0147	CcSEcCtD
Olopatadine—CYP3A4—digestive system—Crohn's disease	0.00198	0.00597	CbGeAlD
Olopatadine—Thirst—Mesalazine—Crohn's disease	0.00196	0.0139	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00175	0.0124	CcSEcCtD
Olopatadine—Dry skin—Mesalazine—Crohn's disease	0.00171	0.0122	CcSEcCtD
Olopatadine—Oedema—Mercaptopurine—Crohn's disease	0.00169	0.012	CcSEcCtD
Olopatadine—Imipramine—SLC22A4—Crohn's disease	0.00168	0.385	CrCbGaD
Olopatadine—Nasopharyngitis—Mesalazine—Crohn's disease	0.00166	0.0119	CcSEcCtD
Olopatadine—Skin disorder—Mercaptopurine—Crohn's disease	0.00164	0.0117	CcSEcCtD
Olopatadine—Influenza—Mesalazine—Crohn's disease	0.00161	0.0115	CcSEcCtD
Olopatadine—Infestation—Azathioprine—Crohn's disease	0.00157	0.0112	CcSEcCtD
Olopatadine—Infestation NOS—Azathioprine—Crohn's disease	0.00157	0.0112	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.0015	0.0107	CcSEcCtD
Olopatadine—Weight increased—Mesalazine—Crohn's disease	0.00146	0.0104	CcSEcCtD
Olopatadine—HRH1—lymph node—Crohn's disease	0.00146	0.00441	CbGeAlD
Olopatadine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00146	0.0104	CcSEcCtD
Olopatadine—Infestation NOS—Mesalazine—Crohn's disease	0.00143	0.0102	CcSEcCtD
Olopatadine—Infestation—Mesalazine—Crohn's disease	0.00143	0.0102	CcSEcCtD
Olopatadine—Ulcer—Prednisone—Crohn's disease	0.00143	0.0102	CcSEcCtD
Olopatadine—Depression—Mesalazine—Crohn's disease	0.00143	0.0102	CcSEcCtD
Olopatadine—Conjunctivitis—Mesalazine—Crohn's disease	0.00139	0.00993	CcSEcCtD
Olopatadine—Urinary tract infection—Mesalazine—Crohn's disease	0.00139	0.00993	CcSEcCtD
Olopatadine—Epistaxis—Mesalazine—Crohn's disease	0.00135	0.00964	CcSEcCtD
Olopatadine—Sinusitis—Mesalazine—Crohn's disease	0.00135	0.00959	CcSEcCtD
Olopatadine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00133	0.00949	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—TYK2—Crohn's disease	0.00133	0.0026	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—TYK2—Crohn's disease	0.00132	0.00259	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR4—Crohn's disease	0.00131	0.00256	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—JAK2—Crohn's disease	0.0013	0.00254	CbGpPWpGaD
Olopatadine—Rhinitis—Mesalazine—Crohn's disease	0.00129	0.0092	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.00129	0.00252	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JAK2—Crohn's disease	0.00129	0.00252	CbGpPWpGaD
Olopatadine—Pharyngitis—Mesalazine—Crohn's disease	0.00128	0.00911	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—TYK2—Crohn's disease	0.00128	0.0025	CbGpPWpGaD
Olopatadine—Immune system disorder—Azathioprine—Crohn's disease	0.00128	0.0091	CcSEcCtD
Olopatadine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00127	0.00908	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—TYK2—Crohn's disease	0.00127	0.00249	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CARD9—Crohn's disease	0.00127	0.00248	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—JAK2—Crohn's disease	0.00127	0.00248	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—JAK2—Crohn's disease	0.00126	0.00247	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—TYK2—Crohn's disease	0.00126	0.00246	CbGpPWpGaD
Olopatadine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00124	0.00885	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00123	0.00241	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.00122	0.00239	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—JAK2—Crohn's disease	0.00121	0.00238	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—TYK2—Crohn's disease	0.0012	0.00236	CbGpPWpGaD
Olopatadine—Eye disorder—Mesalazine—Crohn's disease	0.0012	0.00857	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CARD9—Crohn's disease	0.0012	0.00235	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—JAK2—Crohn's disease	0.0012	0.00234	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—MLN—Crohn's disease	0.00119	0.00233	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00116	0.00228	CbGpPWpGaD
Olopatadine—Immune system disorder—Mesalazine—Crohn's disease	0.00116	0.00829	CcSEcCtD
Olopatadine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00116	0.00827	CcSEcCtD
Olopatadine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00115	0.00822	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—JAK2—Crohn's disease	0.00115	0.00225	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—TYK2—Crohn's disease	0.00115	0.00224	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00114	0.00813	CcSEcCtD
Olopatadine—S100A12—Immune System—MADCAM1—Crohn's disease	0.00112	0.0022	CbGpPWpGaD
Olopatadine—Erythema—Mesalazine—Crohn's disease	0.00112	0.00799	CcSEcCtD
Olopatadine—Malaise—Azathioprine—Crohn's disease	0.00111	0.00791	CcSEcCtD
Olopatadine—Dysgeusia—Mesalazine—Crohn's disease	0.0011	0.00782	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—JAK2—Crohn's disease	0.00109	0.00214	CbGpPWpGaD
Olopatadine—Back pain—Mesalazine—Crohn's disease	0.00108	0.00772	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—TYK2—Crohn's disease	0.00108	0.00212	CbGpPWpGaD
Olopatadine—Muscle spasms—Mesalazine—Crohn's disease	0.00108	0.00768	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TYK2—Crohn's disease	0.00108	0.00211	CbGpPWpGaD
Olopatadine—Vomiting—Mercaptopurine—Crohn's disease	0.00107	0.00764	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00106	0.00208	CbGpPWpGaD
Olopatadine—S100B—Immune System—MADCAM1—Crohn's disease	0.00106	0.00208	CbGpPWpGaD
Olopatadine—Rash—Mercaptopurine—Crohn's disease	0.00106	0.00757	CcSEcCtD
Olopatadine—Dermatitis—Mercaptopurine—Crohn's disease	0.00106	0.00756	CcSEcCtD
Olopatadine—Vision blurred—Mesalazine—Crohn's disease	0.00106	0.00753	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00104	0.00741	CcSEcCtD
Olopatadine—Ill-defined disorder—Mesalazine—Crohn's disease	0.00104	0.00741	CcSEcCtD
Olopatadine—Discomfort—Azathioprine—Crohn's disease	0.00104	0.00737	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—JAK2—Crohn's disease	0.00103	0.00202	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—JAK2—Crohn's disease	0.00103	0.00201	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TYK2—Crohn's disease	0.00102	0.002	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICOSLG—Crohn's disease	0.00102	0.00199	CbGpPWpGaD
Olopatadine—Malaise—Mesalazine—Crohn's disease	0.00101	0.0072	CcSEcCtD
Olopatadine—Nausea—Mercaptopurine—Crohn's disease	0.001	0.00713	CcSEcCtD
Olopatadine—Infection—Azathioprine—Crohn's disease	0.000998	0.00711	CcSEcCtD
Olopatadine—Cough—Mesalazine—Crohn's disease	0.000978	0.00697	CcSEcCtD
Olopatadine—Skin disorder—Azathioprine—Crohn's disease	0.000975	0.00695	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—JAK2—Crohn's disease	0.000972	0.0019	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00097	0.0019	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—SOCS1—Crohn's disease	0.00097	0.0019	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICOSLG—Crohn's disease	0.000961	0.00188	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.00096	0.00188	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000948	0.00675	CcSEcCtD
Olopatadine—Discomfort—Mesalazine—Crohn's disease	0.000943	0.00672	CcSEcCtD
Olopatadine—Dry mouth—Mesalazine—Crohn's disease	0.000933	0.00665	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—NOD1—Crohn's disease	0.000925	0.00181	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.000916	0.00179	CbGpPWpGaD
Olopatadine—Oedema—Mesalazine—Crohn's disease	0.000915	0.00652	CcSEcCtD
Olopatadine—Infection—Mesalazine—Crohn's disease	0.000909	0.00648	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.000908	0.00178	CbGpPWpGaD
Olopatadine—S100A12—Immune System—DEFA5—Crohn's disease	0.000906	0.00177	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNGR2—Crohn's disease	0.000906	0.00177	CbGpPWpGaD
Olopatadine—Dry skin—Prednisone—Crohn's disease	0.000903	0.00643	CcSEcCtD
Olopatadine—Nervous system disorder—Mesalazine—Crohn's disease	0.000897	0.00639	CcSEcCtD
Olopatadine—Skin disorder—Mesalazine—Crohn's disease	0.000889	0.00633	CcSEcCtD
Olopatadine—S100B—Innate Immune System—NOD1—Crohn's disease	0.000875	0.00171	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000867	0.00618	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.000866	0.0017	CbGpPWpGaD
Olopatadine—S100B—Immune System—DEFA5—Crohn's disease	0.000857	0.00168	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNGR2—Crohn's disease	0.000857	0.00168	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—TYK2—Crohn's disease	0.000855	0.00167	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CCR6—Crohn's disease	0.00084	0.00164	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000831	0.00163	CbGpPWpGaD
Olopatadine—Feeling abnormal—Azathioprine—Crohn's disease	0.000828	0.0059	CcSEcCtD
Olopatadine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000821	0.00585	CcSEcCtD
Olopatadine—Dyspnoea—Mesalazine—Crohn's disease	0.000816	0.00581	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—JAK2—Crohn's disease	0.000815	0.0016	CbGpPWpGaD
Olopatadine—Somnolence—Mesalazine—Crohn's disease	0.000813	0.00579	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CCR6—Crohn's disease	0.000794	0.00156	CbGpPWpGaD
Olopatadine—Body temperature increased—Azathioprine—Crohn's disease	0.000794	0.00566	CcSEcCtD
Olopatadine—Abdominal pain—Azathioprine—Crohn's disease	0.000794	0.00566	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00079	0.00563	CcSEcCtD
Olopatadine—Fatigue—Mesalazine—Crohn's disease	0.000789	0.00562	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000788	0.00154	CbGpPWpGaD
Olopatadine—Pain—Mesalazine—Crohn's disease	0.000782	0.00557	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Crohn's disease	0.000778	0.00152	CbGpPWpGaD
Olopatadine—Weight increased—Prednisone—Crohn's disease	0.000775	0.00552	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—GPR65—Crohn's disease	0.000767	0.0015	CbGpPWpGaD
Olopatadine—Depression—Prednisone—Crohn's disease	0.000757	0.00539	CcSEcCtD
Olopatadine—Feeling abnormal—Mesalazine—Crohn's disease	0.000754	0.00537	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000748	0.00533	CcSEcCtD
Olopatadine—Hypersensitivity—Azathioprine—Crohn's disease	0.00074	0.00527	CcSEcCtD
Olopatadine—S100A12—Immune System—CARD9—Crohn's disease	0.000739	0.00145	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Crohn's disease	0.000736	0.00144	CbGpPWpGaD
Olopatadine—Abdominal pain—Mesalazine—Crohn's disease	0.000723	0.00515	CcSEcCtD
Olopatadine—Body temperature increased—Mesalazine—Crohn's disease	0.000723	0.00515	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—Crohn's disease	0.000704	0.00138	CbGpPWpGaD
Olopatadine—S100B—Immune System—CARD9—Crohn's disease	0.000698	0.00137	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.000697	0.00136	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ACKR2—Crohn's disease	0.000687	0.00135	CbGpPWpGaD
Olopatadine—Diarrhoea—Azathioprine—Crohn's disease	0.000687	0.0049	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.000686	0.00134	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.000684	0.00134	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—Crohn's disease	0.000674	0.155	CrCbGaD
Olopatadine—Hypersensitivity—Mesalazine—Crohn's disease	0.000674	0.0048	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—UBE2D1—Crohn's disease	0.000666	0.0013	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—Crohn's disease	0.000665	0.0013	CbGpPWpGaD
Olopatadine—Dizziness—Azathioprine—Crohn's disease	0.000664	0.00473	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.000661	0.00129	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.000659	0.00129	CbGpPWpGaD
Olopatadine—Asthenia—Mesalazine—Crohn's disease	0.000656	0.00468	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—MLN—Crohn's disease	0.000651	0.00128	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	0.000649	0.00127	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—Crohn's disease	0.000648	0.149	CrCbGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.000647	0.00127	CbGpPWpGaD
Olopatadine—Pruritus—Mesalazine—Crohn's disease	0.000647	0.00461	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—RIPK2—Crohn's disease	0.000646	0.00126	CbGpPWpGaD
Olopatadine—Vomiting—Azathioprine—Crohn's disease	0.000639	0.00455	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000638	0.00125	CbGpPWpGaD
Olopatadine—Eye disorder—Prednisone—Crohn's disease	0.000637	0.00454	CcSEcCtD
Olopatadine—Rash—Azathioprine—Crohn's disease	0.000633	0.00451	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—ACKR2—Crohn's disease	0.000633	0.00124	CbGpPWpGaD
Olopatadine—Dermatitis—Azathioprine—Crohn's disease	0.000633	0.00451	CcSEcCtD
Olopatadine—S100B—Innate Immune System—UBE2D1—Crohn's disease	0.00063	0.00123	CbGpPWpGaD
Olopatadine—Headache—Azathioprine—Crohn's disease	0.000629	0.00448	CcSEcCtD
Olopatadine—Diarrhoea—Mesalazine—Crohn's disease	0.000626	0.00446	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.000625	0.00122	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—Crohn's disease	0.000623	0.00122	CbGpPWpGaD
Olopatadine—Immune system disorder—Prednisone—Crohn's disease	0.000615	0.00438	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	0.000614	0.0012	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—RIPK2—Crohn's disease	0.000611	0.0012	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RASGRP1—Crohn's disease	0.000609	0.00119	CbGpPWpGaD
Olopatadine—Dizziness—Mesalazine—Crohn's disease	0.000605	0.00431	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—MLN—Crohn's disease	0.0006	0.00117	CbGpPWpGaD
Olopatadine—Nausea—Azathioprine—Crohn's disease	0.000597	0.00425	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TAB1—Crohn's disease	0.000596	0.00117	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TAGAP—Crohn's disease	0.000596	0.00117	CbGpPWpGaD
Olopatadine—Erythema—Prednisone—Crohn's disease	0.000593	0.00423	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000593	0.00116	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—Crohn's disease	0.000589	0.00115	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—NOD2—Crohn's disease	0.000586	0.00115	CbGpPWpGaD
Olopatadine—Vomiting—Mesalazine—Crohn's disease	0.000582	0.00414	CcSEcCtD
Olopatadine—Rash—Mesalazine—Crohn's disease	0.000577	0.00411	CcSEcCtD
Olopatadine—Dermatitis—Mesalazine—Crohn's disease	0.000576	0.00411	CcSEcCtD
Olopatadine—S100B—Innate Immune System—RASGRP1—Crohn's disease	0.000576	0.00113	CbGpPWpGaD
Olopatadine—Headache—Mesalazine—Crohn's disease	0.000573	0.00408	CcSEcCtD
Olopatadine—S100B—Innate Immune System—TAB1—Crohn's disease	0.000564	0.0011	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—Crohn's disease	0.00056	0.0011	CbGpPWpGaD
Olopatadine—Vision blurred—Prednisone—Crohn's disease	0.000559	0.00398	CcSEcCtD
Olopatadine—S100B—Innate Immune System—NOD2—Crohn's disease	0.000554	0.00108	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—SOCS1—Crohn's disease	0.000552	0.00108	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Prednisone—Crohn's disease	0.00055	0.00392	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000546	0.00107	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—TYK2—Crohn's disease	0.000546	0.00107	CbGpPWpGaD
Olopatadine—Nausea—Mesalazine—Crohn's disease	0.000543	0.00387	CcSEcCtD
Olopatadine—S100A12—Immune System—NOD1—Crohn's disease	0.000539	0.00105	CbGpPWpGaD
Olopatadine—Malaise—Prednisone—Crohn's disease	0.000535	0.00381	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—IL6—Crohn's disease	0.00053	0.00104	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	0.000527	0.00103	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—SOCS1—Crohn's disease	0.000522	0.00102	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—JAK2—Crohn's disease	0.000521	0.00102	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RSPO3—Crohn's disease	0.000521	0.00102	CbGpPWpGaD
Olopatadine—Clomipramine—ALB—Crohn's disease	0.000513	0.118	CrCbGaD
Olopatadine—S100B—Immune System—NOD1—Crohn's disease	0.000509	0.000997	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000508	0.000994	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000501	0.00357	CcSEcCtD
Olopatadine—Nortriptyline—ALB—Crohn's disease	0.000501	0.115	CrCbGaD
Olopatadine—Discomfort—Prednisone—Crohn's disease	0.000499	0.00355	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	0.000498	0.000976	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SEL1L—Crohn's disease	0.000494	0.000967	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CCR6—Crohn's disease	0.000489	0.000958	CbGpPWpGaD
Olopatadine—Oedema—Prednisone—Crohn's disease	0.000484	0.00345	CcSEcCtD
Olopatadine—Infection—Prednisone—Crohn's disease	0.000481	0.00343	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—Crohn's disease	0.000475	0.00338	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—Crohn's disease	0.00047	0.00335	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000469	0.000919	CbGpPWpGaD
Olopatadine—S100B—Immune System—CCR6—Crohn's disease	0.000463	0.000906	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR9—Crohn's disease	0.000452	0.000884	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTPN2—Crohn's disease	0.000447	0.000876	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000444	0.000869	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RBX1—Crohn's disease	0.000442	0.000866	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTPN2—Crohn's disease	0.000423	0.000828	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000422	0.000827	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GPR65—Crohn's disease	0.00042	0.000822	CbGpPWpGaD
Olopatadine—S100B—Immune System—RBX1—Crohn's disease	0.000418	0.000819	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—Crohn's disease	0.000418	0.000818	CbGpPWpGaD
Olopatadine—Fatigue—Prednisone—Crohn's disease	0.000417	0.00297	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CRP—Crohn's disease	0.000416	0.000815	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR9—Crohn's disease	0.000416	0.000814	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR4—Crohn's disease	0.000399	0.000781	CbGpPWpGaD
Olopatadine—Feeling abnormal—Prednisone—Crohn's disease	0.000399	0.00284	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000396	0.000776	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000396	0.00282	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CRP—Crohn's disease	0.000394	0.000771	CbGpPWpGaD
Olopatadine—S100A12—Immune System—UBE2D1—Crohn's disease	0.000388	0.00076	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GPR65—Crohn's disease	0.000387	0.000757	CbGpPWpGaD
Olopatadine—Abdominal pain—Prednisone—Crohn's disease	0.000383	0.00273	CcSEcCtD
Olopatadine—Body temperature increased—Prednisone—Crohn's disease	0.000383	0.00273	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—STAT3—Crohn's disease	0.000382	0.000749	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR4—Crohn's disease	0.000377	0.000739	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ITGA4—Crohn's disease	0.000376	0.000737	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RIPK2—Crohn's disease	0.000376	0.000737	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000372	0.000728	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL3—Crohn's disease	0.000367	0.000718	CbGpPWpGaD
Olopatadine—S100B—Immune System—UBE2D1—Crohn's disease	0.000367	0.000718	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000362	0.000708	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisone—Crohn's disease	0.000357	0.00254	CcSEcCtD
Olopatadine—S100B—Immune System—RIPK2—Crohn's disease	0.000356	0.000696	CbGpPWpGaD
Olopatadine—S100B—Immune System—ITGA4—Crohn's disease	0.000356	0.000696	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RASGRP1—Crohn's disease	0.000355	0.000695	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000354	0.000694	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD79A—Crohn's disease	0.000354	0.000692	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—Crohn's disease	0.000348	0.0797	CrCbGaD
Olopatadine—Asthenia—Prednisone—Crohn's disease	0.000347	0.00247	CcSEcCtD
Olopatadine—S100A12—Immune System—TAB1—Crohn's disease	0.000347	0.00068	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL3—Crohn's disease	0.000347	0.000679	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—Crohn's disease	0.000342	0.00244	CcSEcCtD
Olopatadine—S100A12—Immune System—NOD2—Crohn's disease	0.000341	0.000668	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—MLN—Crohn's disease	0.000339	0.000664	CbGpPWpGaD
Olopatadine—S100B—Immune System—RASGRP1—Crohn's disease	0.000336	0.000657	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD79A—Crohn's disease	0.000334	0.000655	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—Crohn's disease	0.000331	0.00236	CcSEcCtD
Olopatadine—S100B—Immune System—TAB1—Crohn's disease	0.000328	0.000643	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ACKR2—Crohn's disease	0.000325	0.000636	CbGpPWpGaD
Olopatadine—S100B—Immune System—NOD2—Crohn's disease	0.000323	0.000631	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SOCS1—Crohn's disease	0.000321	0.000629	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—Crohn's disease	0.00032	0.00228	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000319	0.000624	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TYK2—Crohn's disease	0.000311	0.000609	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MLN—Crohn's disease	0.000308	0.000603	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—Crohn's disease	0.000308	0.00219	CcSEcCtD
Olopatadine—Rash—Prednisone—Crohn's disease	0.000305	0.00217	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—Crohn's disease	0.000305	0.00217	CcSEcCtD
Olopatadine—S100B—Immune System—SOCS1—Crohn's disease	0.000304	0.000595	CbGpPWpGaD
Olopatadine—Headache—Prednisone—Crohn's disease	0.000303	0.00216	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CCR6—Crohn's disease	0.000299	0.000586	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—JAK2—Crohn's disease	0.000297	0.000581	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TYK2—Crohn's disease	0.000294	0.000576	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL18—Crohn's disease	0.000289	0.000567	CbGpPWpGaD
Olopatadine—Nausea—Prednisone—Crohn's disease	0.000287	0.00205	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CD4—Crohn's disease	0.000281	0.00055	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—JAK2—Crohn's disease	0.00028	0.000549	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000277	0.000541	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR6—Crohn's disease	0.000276	0.000539	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL18—Crohn's disease	0.000274	0.000536	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RBX1—Crohn's disease	0.000271	0.00053	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—Crohn's disease	0.000266	0.000521	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTGER4—Crohn's disease	0.000263	0.000516	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2RA—Crohn's disease	0.000257	0.000503	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2RA—Crohn's disease	0.000243	0.000476	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	0.000243	0.000475	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—Crohn's disease	0.000242	0.000475	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—UBE2D1—Crohn's disease	0.000237	0.000464	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	0.000235	0.00046	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—Crohn's disease	0.000232	0.000455	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RIPK2—Crohn's disease	0.00023	0.00045	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—Crohn's disease	0.000229	0.000449	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL3—Crohn's disease	0.000224	0.000439	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICAM1—Crohn's disease	0.000223	0.000436	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—Crohn's disease	0.00022	0.00043	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	0.000219	0.000428	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RASGRP1—Crohn's disease	0.000217	0.000425	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR9—Crohn's disease	0.000213	0.000418	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICAM1—Crohn's disease	0.000211	0.000413	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GPR65—Crohn's disease	0.000198	0.000389	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SOCS1—Crohn's disease	0.000197	0.000385	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ACKR2—Crohn's disease	0.000192	0.000376	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MLN—Crohn's disease	0.000182	0.000356	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TYK2—Crohn's disease	0.000181	0.000355	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000181	0.000354	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JAK2—Crohn's disease	0.000173	0.000338	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000173	0.000338	CbGpPWpGaD
Olopatadine—S100B—Immune System—TYK2—Crohn's disease	0.000171	0.000335	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SMAD3—Crohn's disease	0.00017	0.000332	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—Crohn's disease	0.00017	0.000332	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAGAP—Crohn's disease	0.000166	0.000326	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—Crohn's disease	0.000164	0.000321	CbGpPWpGaD
Olopatadine—S100B—Immune System—JAK2—Crohn's disease	0.000163	0.00032	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—Crohn's disease	0.00016	0.000314	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2RA—Crohn's disease	0.000157	0.000308	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	0.000156	0.000305	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—Crohn's disease	0.000155	0.000303	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—Crohn's disease	0.000152	0.000298	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—Crohn's disease	0.000151	0.000296	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RSPO3—Crohn's disease	0.000145	0.000285	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—Crohn's disease	0.000144	0.000281	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—Crohn's disease	0.000143	0.00028	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	0.000141	0.000277	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	0.000138	0.00027	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000137	0.000268	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—Crohn's disease	0.000127	0.000248	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.000126	0.000247	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000124	0.000244	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—Crohn's disease	0.00012	0.000235	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.000117	0.00023	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000117	0.000229	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000117	0.000228	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000113	0.000221	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TYK2—Crohn's disease	0.000111	0.000217	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000106	0.000208	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAK2—Crohn's disease	0.000106	0.000207	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000103	0.000201	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—Crohn's disease	9.64e-05	0.000189	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	8.88e-05	0.000174	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—Crohn's disease	8.86e-05	0.000173	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.85e-05	0.000173	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—Crohn's disease	8.37e-05	0.000164	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR6—Crohn's disease	8.35e-05	0.000164	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	8.18e-05	0.00016	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—Crohn's disease	7.75e-05	0.000152	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	7.73e-05	0.000151	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBX1—Crohn's disease	7.55e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	7.43e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	7.35e-05	0.000144	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	6.62e-05	0.00013	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTMR3—Crohn's disease	6.57e-05	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	6.42e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL3—Crohn's disease	6.26e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	6.06e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.5e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.49e-05	0.000107	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—Crohn's disease	5.41e-05	0.000106	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.23e-05	0.000102	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FADS1—Crohn's disease	5.12e-05	0.0001	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	5.02e-05	9.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	4.99e-05	9.78e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX4—Crohn's disease	4.79e-05	9.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.74e-05	9.28e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCKR—Crohn's disease	4.63e-05	9.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.56e-05	8.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.39e-05	8.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.09e-05	6.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAK2—Crohn's disease	2.95e-05	5.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.69e-05	5.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.56e-05	5.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.16e-05	4.24e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—Crohn's disease	1.51e-05	2.96e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—Crohn's disease	1.47e-05	2.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.29e-05	2.52e-05	CbGpPWpGaD
